82 related articles for article (PubMed ID: 661408)
1. [Cirrhosis and blood cholesterol. Apropos of 240 plasma determinations of total cholesterol in patients with cirrhosis of the liver].
Pequegnot H; Guerre J; de La Bouillerie B; Chretien JM; Gerard MJ; Babok A; Guerre Y; Fluteau G
Med Chir Dig; 1978; 7(2):137-40. PubMed ID: 661408
[No Abstract] [Full Text] [Related]
2. Serum lipid and lipoprotein patterns in patients with liver cirrhosis and chronic active hepatitis.
Cicognani C; Malavolti M; Morselli-Labate AM; Zamboni L; Sama C; Barbara L
Arch Intern Med; 1997 Apr; 157(7):792-6. PubMed ID: 9125012
[TBL] [Abstract][Full Text] [Related]
3. [Plasma concentration and elimination behavior of the cardiac glycoside meproscillarin in patients with liver cirrhosis].
Burkert K; Beckmann H
Z Gastroenterol; 1983 Jan; 21(1):34-40. PubMed ID: 6845784
[TBL] [Abstract][Full Text] [Related]
4. May plasma cholesterol level be considered a neoplastic marker in liver disease from cirrhosis to hepatocellular carcinoma?
Venturini I; Amedei R; Modonesi G; Cosenza R; Miglioli L; Cioni G; Zeneroli ML
Ital J Gastroenterol Hepatol; 1999; 31(1):61-5. PubMed ID: 10091105
[TBL] [Abstract][Full Text] [Related]
5. Serum leptin levels in patients with nonalcoholic chronic liver disease.
Nakamuta M; Tada S; Uchimura K; Enjoji M; Kinukawa N; Iwamoto H; Sugimoto R; Shimada M; Ohashi M; Sugimachi K; Nawata H
Hepatogastroenterology; 2001; 48(38):527-32. PubMed ID: 11379347
[TBL] [Abstract][Full Text] [Related]
6. A snack enriched with oral branched-chain amino acids prevents a fall in albumin in patients with liver cirrhosis undergoing chemoembolization for hepatocellular carcinoma.
Takeshita S; Ichikawa T; Nakao K; Miyaaki H; Shibata H; Matsuzaki T; Muraoka T; Honda T; Otani M; Akiyama M; Miuma S; Ozawa E; Fujimito M; Eguchi K
Nutr Res; 2009 Feb; 29(2):89-93. PubMed ID: 19285598
[TBL] [Abstract][Full Text] [Related]
7. [HDL2 and HDL3 cholesterol in hepatic cirrhosis].
Pacifico A; Cherchi GM; Deiana MG; Maioli M
Boll Soc Ital Biol Sper; 1983 Jan; 59(2):199-205. PubMed ID: 6860495
[TBL] [Abstract][Full Text] [Related]
8. [Study of plasma lipids in patients with liver cirrhosis and hepatitis].
Platzer S; Sailer S; Sandhofer F; Braunsteiner H
Wien Klin Wochenschr; 1966 Jan; 78(4):56-8. PubMed ID: 5962258
[No Abstract] [Full Text] [Related]
9. Parallel reduction of plasma levels of high and low molecular weight kininogen in patients with cirrhosis.
Cugno M; Scott CF; Salerno F; Lorenzano E; Müller-Esterl W; Agostoni A; Colman RW
Thromb Haemost; 1999 Nov; 82(5):1428-32. PubMed ID: 10595632
[TBL] [Abstract][Full Text] [Related]
10. [Changes in the erythrocyte in liver cirrhosis: role of cholesterol and plasma phospholipids].
Stufano N; Altomare E; Vendemiale G; Lasorsa G; Romano A; Albano O
Boll Soc Ital Biol Sper; 1985 Jan; 61(1):137-43. PubMed ID: 3977992
[TBL] [Abstract][Full Text] [Related]
11. Does a long pre-operative hospital stay before hepatectomy improve liver dysfunction in HCC patients with chronic liver disease?
Ezaki T; Koyanagi N; Toyomasu T; Ikeda Y; Sugimachi K
Hepatogastroenterology; 1997; 44(14):472-6. PubMed ID: 9164521
[TBL] [Abstract][Full Text] [Related]
12. [Indicators of protein metabolism in chronic hepatitis and liver cirrhosis].
Voloshchuk OA; Fedoruk SG; Rozgon GI; Andrievskaia SE; Kolbasova AN
Vrach Delo; 1978 Dec; (12):74-7. PubMed ID: 743342
[No Abstract] [Full Text] [Related]
13. Serum cholesterol and magnesium in severe cirrhotics.
Hiranandani RT; Shetty M; Patil V; Chakravorty BP
Indian Heart J; 1979; 31(4):218-9. PubMed ID: 489038
[No Abstract] [Full Text] [Related]
14. Treatment of stabilized liver cirrhosis by dehydroepiandrosterone sulphate. I. Evaluation of principal biochemical tests as a whole.
Fassati P; Fassati M; Sonka J; Josifko M
Agressologie; 1973 Aug; 14(4):259-68. PubMed ID: 4369399
[No Abstract] [Full Text] [Related]
15. Serum lipids and lipoproteins in chronic liver disease.
Fehér J; Romics L; Jakab L; Fehér E; Szilvási I; Papp G
Acta Med Acad Sci Hung; 1976; 33(3):217-23. PubMed ID: 1031549
[TBL] [Abstract][Full Text] [Related]
16. Long-term effect of prophylactic endoscopic injection sclerotherapy on liver function.
Murata K; Sugimoto K; Okuda K; Shimizu A; Takase K; Nakano T; Tameda Y
Hepatogastroenterology; 1998; 45(23):1726-30. PubMed ID: 9840136
[TBL] [Abstract][Full Text] [Related]
17. [Changes in the lipid profile in chronic hepatopathies].
Perales J; Angel Lasunción M; Cano A; Martín-Scapa MA; Matíes M; Herrera E
Med Clin (Barc); 1994 Mar; 102(10):364-8. PubMed ID: 8182981
[TBL] [Abstract][Full Text] [Related]
18. Albumin and prealbumin may predict retinol status in patients with liver cirrhosis.
Chang WT; Ker CG; Hung HC; Lee KT; Chen LS; Chiang HC; Huang MC
Hepatogastroenterology; 2008; 55(86-87):1681-5. PubMed ID: 19102369
[TBL] [Abstract][Full Text] [Related]
19. Plasma adrenomedullin levels in patients with hepatic cirrhosis.
Fábrega E; Casafont F; Crespo J; de la Peña J; San Miguel G; de las Heras G; García-Unzueta MT; Amado JA; Pons-Romero F
Am J Gastroenterol; 1997 Oct; 92(10):1901-4. PubMed ID: 9382062
[TBL] [Abstract][Full Text] [Related]
20. Effect of cyclosporin A on serum lipids in primary biliary cirrhosis patients.
Parsons HG; Thirsk JE; Frohlich J; Dias V; Minuk GY
Clin Invest Med; 1989 Dec; 12(6):386-91. PubMed ID: 2612091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
